Press Releases

Recent updates in the news regarding Circuit Therapeutics as well as latest publications.


Significant Contract From DARPA

Posted November 2015

Circuit Therapeutics Awarded Significant Contract From DARPA to Pursue Optogenetic Therapies for Conditions of the Peripheral Nervous System, Including Chronic Pain



Neuroscience 2014

Posted November 2014

Circuit Therapeutics will present studies on optogenetic driven understandings of Parkinson’s Disease on Wednesday, November 19 at the Walter E. Washington Convention Center, Washington DC. These studies demonstrate the power of optogenetic control to develop new models and therapeutically relevant…


Michael J. Fox Grant

Posted September 2014

Building on the efficacy of deep brain stimulation (DBS) for Parkinson’s Disease, and capitalizing on optogenetic precision, Circuit is developing a more precise, efficacious and tolerable therapy for the benefit of patients. The Michael J Fox Foundation has awarded a grant...


BioCentury Article

Posted January 2014

Circuit Therapeutics Inc.’s first deal provides a glimpse into how the biotech views the future of psychiatry therapeutics — a space focused on clusters of linked symptoms rather than indications. Partner Boehringer Ingelheim GmbH is an early adopter of Circuit’s…


Boehringer Ingelheim Partnership

Posted December 2013

Circuit Therapeutics and Boehringer Ingelheim announce signature of a research partnership agreement to discover new approaches to treating psychiatric disorders


Get in Touch

Have questions or simply looking to find out more about partnering with us? Pick up the phone or send a quick message to find out more about our vision or partnering with us.